India
· Delayed Price · Currency is INR Bayer CropScience Statistics
Total Valuation
Bayer CropScience has a market cap or net worth of INR 255.74 billion. The enterprise value is 246.27 billion.
| Market Cap | 255.74B |
| Enterprise Value | 246.27B |
Important Dates
The next estimated earnings date is Monday, February 3, 2025.
| Earnings Date | Feb 3, 2025 |
| Ex-Dividend Date | Nov 28, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 19.01M |
Valuation Ratios
The trailing PE ratio is 44.12.
| PE Ratio | 44.12 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 8.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 33.14, with an EV/FCF ratio of 24.02.
| EV / Earnings | 42.49 |
| EV / Sales | 4.81 |
| EV / EBITDA | 33.14 |
| EV / EBIT | 36.36 |
| EV / FCF | 24.02 |
Financial Position
The company has a current ratio of 2.22, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.22 |
| Quick Ratio | 1.43 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.03 |
| Interest Coverage | 43.42 |
Financial Efficiency
Return on equity (ROE) is 18.66% and return on invested capital (ROIC) is 13.42%.
| Return on Equity (ROE) | 18.66% |
| Return on Assets (ROA) | 8.08% |
| Return on Capital (ROIC) | 13.42% |
| Revenue Per Employee | 38.84M |
| Profits Per Employee | 4.40M |
| Employee Count | 1,317 |
| Asset Turnover | 0.98 |
| Inventory Turnover | 2.12 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.80% in the last 52 weeks. The beta is 0.40, so Bayer CropScience's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | +1.80% |
| 50-Day Moving Average | 6,201.38 |
| 200-Day Moving Average | 6,068.98 |
| Relative Strength Index (RSI) | 37.46 |
| Average Volume (20 Days) | 25,555 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bayer CropScience had revenue of INR 51.15 billion and earned 5.80 billion in profits. Earnings per share was 128.97.
| Revenue | 51.15B |
| Gross Profit | 20.20B |
| Operating Income | 6.77B |
| Pretax Income | 7.36B |
| Net Income | 5.80B |
| EBITDA | 7.09B |
| EBIT | 6.77B |
| Earnings Per Share (EPS) | 128.97 |
Balance Sheet
The company has 9.80 billion in cash and 334.00 million in debt, giving a net cash position of 9.47 billion.
| Cash & Cash Equivalents | 9.80B |
| Total Debt | 334.00M |
| Net Cash | 9.47B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 30.82B |
| Book Value Per Share | 685.86 |
| Working Capital | 25.24B |
Cash Flow
In the last 12 months, operating cash flow was 10.75 billion and capital expenditures -501.00 million, giving a free cash flow of 10.25 billion.
| Operating Cash Flow | 10.75B |
| Capital Expenditures | -501.00M |
| Free Cash Flow | 10.25B |
| FCF Per Share | n/a |
Margins
Gross margin is 39.48%, with operating and profit margins of 13.24% and 11.33%.
| Gross Margin | 39.48% |
| Operating Margin | 13.24% |
| Pretax Margin | 14.38% |
| Profit Margin | 11.33% |
| EBITDA Margin | 13.85% |
| EBIT Margin | 13.24% |
| FCF Margin | 20.04% |
Dividends & Yields
Bayer CropScience does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | -7.41% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 108.44% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.00% |
| Earnings Yield | 2.26% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |